Mia Phillipson on Twitter

“Am super proud of this innovative approach enabling the use of short-lived chemokines to treat disease. And of the team making this possible. Thank you,thank you,thank you! @KAWstiftelsen @ilyapharma @scilifelab @stiftelse @uppsalauni @_SLU @H2020Projects https://t.co/7EdwI7oEqI”

Twitter
Communiqué de presse commun : Négociation branche #ATMP : améliorer la prévention et la réparation.
Une nouvelle phase de discussion, celle de la négociation interprofessionnelle, s'est ouverte ce 1er décembre.
FO reste mobilisée!

RT @EatrisEric: Today is the EATRIS & European Medicines Agency (EMA) webinar on "Support for Academic & Non-Profit #ATMP Developers" with Partick Celis, the Lead Scientific Officer in EMA’s Advanced Therapies Office.

👉 Find out more & register to join here: https://eatris.eu/events/eatris-and-ema-present-webinar-on-support-for-academic-and-non-profit-atmp-developers/ @EMA_News

🐦🔗: https://n.respublicae.eu/EMA_News/status/1598325445224710144

EATRIS and EMA Present: Webinar on Support for Academic and Non-Profit ATMP Developers - EATRIS

EATRIS

@ColoniMarco

Ah, le terapie ad #mRNA non rientrano nella definizione di "#sperimentali", non sono nemmeno terapie avanzate (#ATMP).

Si puo discutere del resto, ma partiamo una base di realtà, e non da siti attendibili al pari di ImolaOggi.

Auguro anche a te una magnifica giornata!

2/2

Accident du travail/maladie professionnelle : nouvelle procédure au 1er décembre 2019

La procédure d’instruction des accidents du travail et des maladies (AT/MP) change au 1er décembre. Explications des juristes de la Fnath